Related Experiment Video
Updated: Jul 16, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Smoking-related interstitial lung diseases].
1Institut für Röntgendiagnostik, TU München, Klinikum rechts der Isar. Katharina.Marten@roe.med.tu-muenchen.de
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|February 28, 2007
Summary
Smoking significantly impacts lung health, causing interstitial lung diseases (ILDs) like respiratory bronchiolitis and desquamative interstitial pneumonia. These conditions often coexist, complicating high-resolution computed tomography (HRCT) findings, and their link to pulmonary fibrosis requires further research.
Area of Science:
- Pulmonology
- Radiology
- Pathology
Background:
- Smoking is a primary risk factor for several interstitial lung diseases (ILDs).
- Key smoking-related ILDs include respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, desquamative interstitial pneumonia, and Langerhans' cell histiocytosis.
- These distinct ILDs can present concurrently, leading to complex radiological patterns.
Purpose of the Study:
- To review the spectrum of smoking-related interstitial lung diseases.
- To highlight the frequent coexistence of these ILDs.
- To emphasize the diagnostic challenges posed by overlapping conditions on HRCT.
Main Methods:
- Review of relevant literature on smoking-related ILDs.
- Analysis of high-resolution computed tomography (HRCT) findings in these conditions.
- Discussion of the pathological features and clinical presentations.
Main Results:
- Respiratory bronchiolitis, RB-ILD, DIP, and LCH are the principal smoking-related ILDs.
- Coexistence of these ILDs is common, contributing to complex HRCT patterns.
- The precise role of smoking in the pathogenesis of pulmonary fibrosis remains to be fully elucidated.
Conclusions:
- Smoking-related ILDs represent a spectrum of disease, often overlapping.
- Accurate diagnosis requires integrating clinical, radiological, and pathological information.
- Further research is necessary to understand smoking's role in developing pulmonary fibrosis.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...